6 Pharmaceutical Stocks to Buy Now

PATH, TTPH, MSLI, WPI, IPXL, MYL improve in weekly rankings

   
6 Pharmaceutical Stocks to Buy Now

The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

NuPathe Inc. (PATH) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. NuPathe develops pharmaceutical products used for the treatment and management of neurological and psychiatric diseases. In Portfolio Grader’s specific subcategories of Earnings Momentum and Earnings Revisions, PATH also gets A’s. For more information, get Portfolio Grader’s complete analysis of PATH stock.

This is a strong week for Tetraphase Pharmaceuticals, Inc. (TTPH). The company’s rating climbs to B from the previous week’s C. For more information, get Portfolio Grader’s complete analysis of TTPH stock.

Merus Labs International Inc. (MSLI) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Meru Labs International acquires and licenses niche branded pharmaceutical products in the United States and Canada. For more information, get Portfolio Grader’s complete analysis of MSLI stock.

This week, Watson Pharmaceuticals (WPI) pushes up from a B to an A rating. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock.

Impax Laboratories, Inc. (IPXL) boosts its rating from a C to a B this week. Impax Laboratories develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. For more information, get Portfolio Grader’s complete analysis of IPXL stock.

This week, Mylan’s (MYL) ratings are up from a B last week to an A. Mylan is a global generic and specialty pharmaceuticals company. For more information, get Portfolio Grader’s complete analysis of MYL stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2014/06/6-pharmaceutical-stocks-to-buy-now-path-ttph-msli/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.